118 related articles for article (PubMed ID: 14640830)
1. Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD?
Whalen CK; Jamner LD; Henker B; Gehricke JG; King PS
Psychol Addict Behav; 2003 Dec; 17(4):332-5. PubMed ID: 14640830
[TBL] [Abstract][Full Text] [Related]
2. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.
Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K
Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598
[TBL] [Abstract][Full Text] [Related]
3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
4. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.
Kollins SH; McClernon FJ; Fuemmeler BF
Arch Gen Psychiatry; 2005 Oct; 62(10):1142-7. PubMed ID: 16203959
[TBL] [Abstract][Full Text] [Related]
5. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
Faraone SV; Biederman J; Wilens TE; Adamson J
Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
[TBL] [Abstract][Full Text] [Related]
6. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents.
Tercyak KP; Lerman C; Audrain J
J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):799-805. PubMed ID: 12108804
[TBL] [Abstract][Full Text] [Related]
7. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder.
Biederman J; Monuteaux MC; Mick E; Wilens TE; Fontanella JA; Poetzl KM; Kirk T; Masse J; Faraone SV
Biol Psychiatry; 2006 Feb; 59(3):258-64. PubMed ID: 16154546
[TBL] [Abstract][Full Text] [Related]
8. Can we prevent smoking in children with ADHD: a review of the literature.
Modesto-Lowe V; Danforth JS; Neering C; Easton C
Conn Med; 2010 Apr; 74(4):229-36. PubMed ID: 20441004
[TBL] [Abstract][Full Text] [Related]
9. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
11. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.
Lerman C; Audrain J; Tercyak K; Hawk LW; Bush A; Crystal-Mansour S; Rose C; Niaura R; Epstein LH
Nicotine Tob Res; 2001 Nov; 3(4):353-9. PubMed ID: 11694203
[TBL] [Abstract][Full Text] [Related]
12. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
Gehricke JG; Hong N; Whalen CK; Steinhoff K; Wigal TL
Psychol Addict Behav; 2009 Dec; 23(4):644-55. PubMed ID: 20025370
[TBL] [Abstract][Full Text] [Related]
15. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
Kordon A; Kahl KG
Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
[TBL] [Abstract][Full Text] [Related]
16. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
Wilens TE; Biederman J
J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
18. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and influences on self-reported smoking among adolescents with mild learning disabilities, attention deficit hyperactivity disorder, and their typically developing peers.
Kalyva E
J Intellect Disabil; 2007 Sep; 11(3):267-79. PubMed ID: 17846049
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
